Literature DB >> 16616141

Evidence that low doses of Taxol enhance the functional transactivatory properties of p53 on p21 waf promoter in MCF-7 breast cancer cells.

M Luisa Panno1, Francesca Giordano, Fabrizia Mastroianni, Catia Morelli, Elvira Brunelli, M Grazia Palma, Michele Pellegrino, Saveria Aquila, Antonella Miglietta, Loredana Mauro, Daniela Bonofiglio, Sebastiano Andò.   

Abstract

In the present study, we evidence how in breast cancer cells low doses of Taxol for 18 h determined the upregulation of p53 and p21 waf expression concomitantly with a decrease of the anti-apoptotic Bcl-2. P53 and its gene product, the mdm2 protein, in treated cells exhibits a prevalent nuclear compartmentalization, thus potentiating p53 transactivatory properties. Indeed, the most important finding of this study consists with the evidence that Taxol at lower concentrations is able to produce the activation of p21 promoter via p53. Prolonged exposure of MCF-7 cells to Taxol (48 h) resulted in an increased co-association between p21 and PCNA compared to control and this well fits with the simultaneous block of cell cycle into the G2/M phase.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16616141     DOI: 10.1016/j.febslet.2006.03.055

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  7 in total

1.  P53 is transported into the nucleus via an Hsf1-dependent nuclear localization mechanism.

Authors:  Qiang Li; Jesse D Martinez
Journal:  Mol Carcinog       Date:  2010-12-10       Impact factor: 4.784

2.  Cyclic pifithrin-alpha sensitizes wild type p53 tumor cells to antimicrotubule agent-induced apoptosis.

Authors:  Valentina Zuco; Franco Zunino
Journal:  Neoplasia       Date:  2008-06       Impact factor: 5.715

3.  Targeting the actin/tropomyosin cytoskeleton in epithelial ovarian cancer reveals multiple mechanisms of synergy with anti-microtubule agents.

Authors:  Xing Xu; Yao Wang; Nicole S Bryce; Katrina Tang; Nicola S Meagher; Eun Young Kang; Linda E Kelemen; Martin Köbel; Susan J Ramus; Michael Friedlander; Caroline E Ford; Edna C Hardeman; Peter W Gunning
Journal:  Br J Cancer       Date:  2021-05-12       Impact factor: 7.640

Review 4.  Platinum drugs and taxanes: can we overcome resistance?

Authors:  Elena V Sazonova; Gelina S Kopeina; Evgeny N Imyanitov; Boris Zhivotovsky
Journal:  Cell Death Discov       Date:  2021-06-26

5.  LIMK2 mediates resistance to chemotherapeutic drugs in neuroblastoma cells through regulation of drug-induced cell cycle arrest.

Authors:  Cristina Gamell; Alice V Schofield; Randy Suryadinata; Boris Sarcevic; Ora Bernard
Journal:  PLoS One       Date:  2013-08-21       Impact factor: 3.240

6.  Naringenin suppresses K562 human leukemia cell proliferation and ameliorates Adriamycin-induced oxidative damage in polymorphonuclear leukocytes.

Authors:  Rui-Fang Li; Ying-Qian Feng; Jun-Hui Chen; Lin-Tong Ge; Shu-Yuan Xiao; Xue-Lan Zuo
Journal:  Exp Ther Med       Date:  2015-01-16       Impact factor: 2.447

7.  Fungal 7-epi-10-deacetyltaxol produced by an endophytic Pestalotiopsis microspora induces apoptosis in human hepatocellular carcinoma cell line (HepG2).

Authors:  Kamalraj Subban; Satpal Singh; Ramesh Subramani; Muthumary Johnpaul; Jayabaskaran Chelliah
Journal:  BMC Complement Altern Med       Date:  2017-11-28       Impact factor: 3.659

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.